Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1990
A full-field modular gamma cameraT D Milster, J N Aarsvold, H H Barrett, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1993
A stationary hemispherical SPECT imager for three-dimensional brain imagingR K Rowe, J N Aarsvold, H H Barrett, et al.AJNR. American Journal of Neuroradiology|July 6, 2023
Outcomes of Preoperative Transophthalmic Artery Embolization of Meningiomas: A Systematic Review with a Focus on Embolization AgentM A Essibayi, M Zakirova, K M Phipps, et al.Respiratory Medicine|September 8, 2020
COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severityMohsin Sheraz Mughal, Ikwinder Preet Kaur, Ali R Jaffery, et al.Innovations (Philadelphia, Pa.)|April 2, 2020
Switching from Thoracoscopic to Robotic Platform for Lobectomy: Report of Learning Curve and OutcomeEric C Lee, Richard S Lazzaro, Lawrence R Glassman, et al.Genetics|January 10, 2002
Insertional mutagenesis of genes required for seed development in Arabidopsis thalianaJ McElver, I Tzafrir, G Aux, et al.Annals of Diagnostic Pathology|May 15, 2021
Diffuse interstitial pneumonia-like/macrophage activation syndrome-like changes in patients with COVID-19 correlate with length of illnessJuan C Felix, Yuri M Sheinin, David Suster, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 20, 2007
Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphomaA M Evens, J K Altman, B B Mittal, et al.Nature Medicine|February 12, 2025
Preeclampsia risk prediction from prenatal cell-free DNA screeningMohamed Adil, Teodora R Kolarova, Anna-Lisa Doebley, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol QK L Jhaveri, X V Wang, V Makker, et al.Pageof 18